Volume 3, 2017
Special Issue: "Musculoskeletal tumors: Current approaches and controversies" Guest Editor: A. Kulidjian
Article Number 54
Number of page(s) 10
Section Knee
Published online 14 September 2017
  1. Dorfman HD, Czerniak B (1998) Bone tumors. St. Louis, Mosby. [Google Scholar]
  2. Randall RL (2003) Giant cell tumor of the sacrum. Neurosurg Focus 15(2), E13. [CrossRef] [Google Scholar]
  3. Campanacci M, Baldini N, Boriani S, Sudanese A (1987) Giant-cell tumor of bone. J Bone Joint Surg Am 69(1), 106–114. [PubMed] [Google Scholar]
  4. Ruggieri P, Mavrogenis AF, Ussia G, Angelini A, Papagelopoulos PJ, Mercuri M (2010) Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor. Clin Orthop Relat Res 468(11), 2954–2961. [CrossRef] [PubMed] [Google Scholar]
  5. Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, Kroep J, Grimer R, Reichardt P, Rutkowski P, Schuetze S, Skubitz K, Staddon A, Thomas D, Qian Y, Jacobs I (2013) Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol 14(9), 901–908. [CrossRef] [PubMed] [Google Scholar]
  6. Turcotte RE (2006) Giant cell tumor of bone. Orthop Clin North Am 37(1), 35–51. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. Zhang K, Chen K, Zhou M, Chen H, Lu J, Yang H (2015) Extremely large giant-cell tumor of sacrum with successful resection via posterior approach. Spine J 15(7), 1684–1685. [CrossRef] [PubMed] [Google Scholar]
  8. Feigenberg SJ, Marcus RBJr., Zlotecki RA, Scarborough MT, Berrey BH, Enneking WF (2003) Radiation therapy for giant cell tumors of bone. Clin Orthop Relat Res 411, 207–216. [CrossRef] [Google Scholar]
  9. Reid R, Banerjee S, Sciot R (2002) Giant cell tumour, in The WHO Classification of tumors. Pathology and genetics: tumors of soft tissue and bone. Fletcher D, Unni K, Mertens F, Editors. Lyon, France, IARC Press. [Google Scholar]
  10. Kransdorf M, Murphey M (2009) Giant cell tumor, in The imaging of bone tumors and tumor-like lesions. Davies M, Sundaram M, James S, Editors. Berlin, Heidelberg, Springer-Verlag. [Google Scholar]
  11. Dahlin DC, Cupps RE, Johnson EWJr. (1970) Giant-cell tumor: a study of 195 cases. Cancer 25(5), 1061–1070. [CrossRef] [PubMed] [Google Scholar]
  12. Resnick D (1995) Diagnosis of bone and joint disorders, 3rd edn. Philadelphia, Saunders. [Google Scholar]
  13. Unni KK, Dahlin DC (1996) Dahlin’s bone tumors: general aspects and data on 11,087 cases, 5th edn. Philadelphia, Lippincott-Raven. [Google Scholar]
  14. Resnick D, Kyriakos M, Greenway G (2002) Tumors and tumor-like lesions of bone: imaging and pathology of specific lesions, in The diagnosis of bone and joint disorders, 4th edn. Resnick D, Editor. Philadelphia, Saunders. [Google Scholar]
  15. Thangaraj R, Grimer RJ, Carter SR, Stirling AJ, Spilsbury J, Spooner D (2010) Giant cell tumour of the sacrum: a suggested algorithm for treatment. Eur Spine J 19(7), 1189–1194. [CrossRef] [PubMed] [Google Scholar]
  16. van der Heijden L, Dijkstra PD, van de Sande MA, Kroep JR, Nout RA, van Rijswijk CS, Bovée JV, Hogendoorn PC, Gelderblom H (2014) The clinical approach toward giant cell tumor of bone. Oncologist 19(5), 550–561. [CrossRef] [PubMed] [Google Scholar]
  17. van der Heijden L, van de Sande MA, van der Geest IC, Schreuder HW, van Royen BJ, Jutte PC, Bramer JA, Öner FC, van Noort-Suijdendorp AP, Kroon HM, Dijkstra PD (2014) Giant cell tumors of the sacrum-a nationwide study on midterm results in 26 patients after intralesional excision. Eur Spine J 23(9), 1949–1962. [CrossRef] [PubMed] [Google Scholar]
  18. Jaffe HL, Lichtenstein L, Portis RB (1940) Giant cell tumor of bone. Its pathologic appearance, grading, supposed variants and treatment. Arch Pathol 30(3), 993–1031. [Google Scholar]
  19. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 415, 4–18. [CrossRef] [Google Scholar]
  20. Abat F, Almenara M, Peiro A, Trullols L, Bague S, Gracia I (2015) Giant cell tumour of bone: a series of 97 cases with a mean follow-up of 12 years. Rev Esp Cir Ortop Traumatol 59(1), 59–65. [PubMed] [Google Scholar]
  21. Wang H, Wan N, Hu Y (2012) Giant cell tumour of bone: a new evaluating system is necessary. Int Orthop 36(12), 2521–2527. [CrossRef] [PubMed] [Google Scholar]
  22. Levine E, De Smet AA, Neff JR (1984) Role of radiologic imaging in management planning of giant cell tumor of bone. Skeletal Radiol 12(2), 79–89. [CrossRef] [PubMed] [Google Scholar]
  23. Chakarun CJ, Forrester DM, Gottsegen CJ, Patel DB, White EA, Matcuk GRJr. (2013) Giant cell tumor of bone: review, mimics, and new developments in treatment. Radiographics 33(1), 197–211. [CrossRef] [PubMed] [Google Scholar]
  24. Aoki J, Tanikawa H, Ishii K, Seo GS, Karakida O, Sone S, Ichikawa T, Kachi K (1996) MR findings indicative of hemosiderin in giant-cell tumor of bone: frequency, cause, and diagnostic significance. AJR Am J Roentgenol 166(1), 145–148. [CrossRef] [PubMed] [Google Scholar]
  25. Herman SD, Mesgarzadeh M, Bonakdarpour A, Dalinka MK (1987) The role of magnetic resonance imaging in giant cell tumor of bone. Skeletal Radiol 16(8), 635–643. [CrossRef] [PubMed] [Google Scholar]
  26. Kaplan PA, Murphey M, Greenway G, Resnick D, Sartoris DJ, Harms S (1987) Fluid-fluid levels in giant cell tumors of bone: report of two cases. J Comput Tomogr 11(2), 151–155. [CrossRef] [PubMed] [Google Scholar]
  27. Hudson TM, Schiebler M, Springfield DS, Enneking WF, Hawkins IFJr., Spanier SS (1984) Radiology of giant cell tumors of bone: computed tomography, arthro-tomography, and scintigraphy. Skeletal Radiol 11(2), 85–95. [CrossRef] [PubMed] [Google Scholar]
  28. Anchan C (2008) Giant cell tumor of bone with secondary aneurysmal bone cyst. Int J Shoulder Surg 2(3), 68. [CrossRef] [Google Scholar]
  29. Levine E, De Smet AA, Neff JR, Martin NL (1984) Scintigraphic evaluation of giant cell tumor of bone. AJR Am J Roentgenol 143(2), 343–348. [CrossRef] [PubMed] [Google Scholar]
  30. Simon MA, Kirchner PT (1980) Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging. J Bone Joint Surg Am 62(5), 758–764. [CrossRef] [PubMed] [Google Scholar]
  31. Grote HJ, Braun M, Kalinski T, Pomjanski N, Back W, Bleyl U, Böcking A, Roessner A (2004) Spontaneous malignant transformation of conventional giant cell tumor. Skeletal Radiol 33(3), 169–175. [CrossRef] [PubMed] [Google Scholar]
  32. Bertoni F, Bacchini P, Staals EL (2003) Malignancy in giant cell tumor of bone. Cancer 97(10), 2520–2529. [CrossRef] [PubMed] [Google Scholar]
  33. Manaster BJ, Doyle AJ (1993) Giant cell tumors of bone. Radiol Clin North Am 31(2), 299–323. [PubMed] [Google Scholar]
  34. Nusbacher N, Sclafani SJ, Birla SR (1981) Case report 155. Polyostotic Paget disease complicated by benign giant cell tumor of left clavicle, Skeletal Radiol 6(3), 233–235. [Google Scholar]
  35. Mavrogenis AF, Angelini A, Errani C, Rimondi E (2014) How should musculoskeletal biopsies be performed? Orthopedics 37(9), 585–588. [CrossRef] [PubMed] [Google Scholar]
  36. Rimondi E, Rossi G, Bartalena T, Ciminari R, Alberghini M, Ruggieri P, Errani C, Angelini A, Calabrò T, Abati CN, Balladelli A, Tranfaglia C, Mavrogenis AF, Vanel D, Mercuri M (2011) Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2027 cases. Eur J Radiol 77(1), 34–42. [CrossRef] [PubMed] [Google Scholar]
  37. Thomas DM (2012) RANKL, denosumab, and giant cell tumor of bone. Curr Opin Oncol 24(4), 397–403. [CrossRef] [PubMed] [Google Scholar]
  38. Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E, Mariette X (2002) RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol 117(2), 210–216. [CrossRef] [PubMed] [Google Scholar]
  39. Liao TS, Yurgelun MB, Chang SS, Zhang HZ, Murakami K, Blaine TA, Parisien MV, Kim W, Winchester RJ, Lee FY (2005) Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J Orthop Res 23(1), 203–209. [CrossRef] [PubMed] [Google Scholar]
  40. Rao UN, Goodman M, Chung WW, Swalski P, Pal R, Finkelstein S (2005) Molecular analysis of primary and recurrent giant cell tumors of bone. Cancer Genet Cytogenet 158(2), 126–136. [CrossRef] [PubMed] [Google Scholar]
  41. Gorunova L, Vult von Steyern F, Storlazzi CT, Bjerkehagen B, Follerås G, Heim S, Mandahl N, Mertens F (2009) Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations. Genes Chromosomes Cancer 48(7), 583–602. [CrossRef] [PubMed] [Google Scholar]
  42. Forsyth RG, De Boeck G, Bekaert S, De Meyer T, Taminiau AH, Uyttendaele D, Roels H, Praet MM, Hogendoorn PC (2008) Telomere biology in giant cell tumour of bone. J Pathol 214(5), 555–563. [CrossRef] [PubMed] [Google Scholar]
  43. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H, Nik-Zainal S, Martin S, McLaren S, Goody V, Robinson B, Butler A, Teague JW, Halai D, Khatri B, Myklebost O, Baumhoer D, Jundt G, Hamoudi R, Tirabosco R, Amary MF, Futreal PA, Stratton MR, Campbell PJ, Flanagan AM (2013) Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45(12), 1479–1482. [CrossRef] [PubMed] [Google Scholar]
  44. Oda Y, Sakamoto A, Saito T, Matsuda S, Tanaka K, Iwamoto Y, Tsuneyoshi M (2001) Secondary malignant giant-cell tumour of bone: molecular abnormalities of p53 and H-ras gene correlated with malignant transformation. Histopathology 39(6), 629–637. [CrossRef] [PubMed] [Google Scholar]
  45. Saito T, Mitomi H, Izumi H, Suehara Y, Okubo T, Torigoe T, Takagi T, Kaneko K, Sato K, Matsumoto T, Yao T (2011) A case of secondary malignant giant-cell tumor of bone with p53 mutation after long-term follow-up. Hum Pathol 42(5), 727–733. [CrossRef] [PubMed] [Google Scholar]
  46. Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G (2008) Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 134(9), 969–978. [CrossRef] [PubMed] [Google Scholar]
  47. Sanerkin NG (1980) Malignancy, aggressiveness, and recurrence in giant cell tumor of bone. Cancer 46(7), 1641–1649. [CrossRef] [PubMed] [Google Scholar]
  48. Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ (2001) From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics 21(5), 1283–1309. [CrossRef] [PubMed] [Google Scholar]
  49. Dominkus M, Ruggieri P, Bertoni F, Briccoli A, Picci P, Rocca M, Mercuri M (2006) Histologically verified lung metastases in benign giant cell tumours. 14 Cases from a single institution. Int Orthop 30(6), 499–504. [CrossRef] [PubMed] [Google Scholar]
  50. Donthineni R, Boriani L, Ofluoglu O, Bandiera S (2009) Metastatic behaviour of giant cell tumour of the spine. Int Orthop 33(2), 497–501. [CrossRef] [PubMed] [Google Scholar]
  51. Siebenrock KA, Unni KK, Rock MG (1998) Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up. J Bone Joint Surg Br 80(1), 43–47. [CrossRef] [PubMed] [Google Scholar]
  52. Lewis VO. 2007. What’s new in musculoskeletal oncology. J Bone Joint Surg Am 89(6), 1399–1407. [CrossRef] [PubMed] [Google Scholar]
  53. Mirra JM, Picci P, Gold RH (1989) Bone tumors: clinical, radiologic, and pathologic correlations. Philadelphia, Lea & Febiger. [Google Scholar]
  54. Horvai A, Unni KK (2006) Premalignant conditions of bone. J Orthop Sci 11(4), 412–423. [CrossRef] [PubMed] [Google Scholar]
  55. Haskell A, Wodowoz O, Johnston JO (2003) Metachronous multicentric giant cell tumor: a case report and literature review. Clin Orthop Relat Res 412, 162–168. [CrossRef] [Google Scholar]
  56. Cummins CA, Scarborough MT, Enneking WF (1996) Multicentric giant cell tumor of bone. Clin Orthop Relat Res 322, 245–252. [CrossRef] [Google Scholar]
  57. Bandyopadhyay R, Biswas S, Bandyopadhyay SK, Ray MM (2016) Synchronous multicentric giant cell tumor. J Cancer Res Ther 6(1), 106–108. [CrossRef] [Google Scholar]
  58. Morey V, Sankineani SR, Kumar R (2014) Multifocal metachronous giant cell tumour in bilateral upper limb: a rare case presentation. Musculoskelet Surg 98(2), 165–169. [CrossRef] [PubMed] [Google Scholar]
  59. Kafchitsas K, Habermann B, Proschek D, Kurth A, Eberhardt C (2010) Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence. Anticancer Res 30(9), 3795–3799. [PubMed] [Google Scholar]
  60. Zhen W, Yaotian H, Songjian L, Ge L, Qingliang W (2004) Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft. J Bone Joint Surg Br 86(2), 212–216. [CrossRef] [PubMed] [Google Scholar]
  61. Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M (2010) Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev 36(1), 1–7. [CrossRef] [PubMed] [Google Scholar]
  62. Salunke AA, Chen Y, Chen X, Tan JH, Singh G, Tai BC, Khin LW, Puhaindran ME (2015) Does pathological fracture affect the rate of local recurrence in patients with a giant cell tumour of bone? A meta-analysis. Bone Joint J 97-B(11), 1566–1571. [CrossRef] [PubMed] [Google Scholar]
  63. Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Follerås G (2008) Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop 79(1), 86–93. [CrossRef] [PubMed] [Google Scholar]
  64. Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH (2011) Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res 469(2), 591–599. [CrossRef] [PubMed] [Google Scholar]
  65. Capanna R, Fabbri N, Bettelli G (1990) Curettage of giant cell tumor of bone. The effect of surgical technique and adjuvants on local recurrence rate. Chir Organi Mov 75(1 Suppl), 206. [PubMed] [Google Scholar]
  66. Durr HR, Maier M, Jansson V, Baur A, Refior HJ (1999) Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone. Eur J Surg Oncol 25(6), 610–618. [CrossRef] [PubMed] [Google Scholar]
  67. Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R (2001) Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol 27(2), 200–202. [CrossRef] [PubMed] [Google Scholar]
  68. Gaston CL, Bhumbra R, Watanuki M, Abudu AT, Carter SR, Jeys LM, Tillman RM, Grimer RJ (2011) Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? J Bone Joint Surg Br 93(12), 1665–1669. [CrossRef] [PubMed] [Google Scholar]
  69. van der Heijden L, van de Sande MA, Dijkstra PD (2012) Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones. Acta Orthop 83(4), 401–405. [CrossRef] [PubMed] [Google Scholar]
  70. Boons HW, Keijser LC, Schreuder HW, Pruszczynski M, Lemmens JA, Veth RP (2002) Oncologic and functional results after treatment of giant cell tumors of bone. Arch Orthop Trauma Surg 122(1), 17–23. [CrossRef] [PubMed] [Google Scholar]
  71. Ghert MA, Rizzo M, Harrelson JM, Scully SP (2002) Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res 400, 201–210. [CrossRef] [Google Scholar]
  72. Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM, Canadian Sarcoma Group (2002) Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res 397, 248–258. [CrossRef] [Google Scholar]
  73. Ward WG, Sr, Li GIII (2002) Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res 397, 259–270. [CrossRef] [Google Scholar]
  74. O’Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ (1994) Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am 76(12), 1827–1833. [CrossRef] [PubMed] [Google Scholar]
  75. Wada T, Kaya M, Nagoya S, Kawaguchi S, Isu K, Yamashita T, Yamawaki S, Ishii S (2002) Complications associated with bone cementing for the treatment of giant cell tumors of bone. J Orthop Sci 7(2), 194–198. [CrossRef] [PubMed] [Google Scholar]
  76. Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH (2011) Recurrent giant cell tumor of long bones: analysis of surgical management. Clin Orthop Relat Res 469(4), 1181–1187. [CrossRef] [PubMed] [Google Scholar]
  77. Balke M, Ahrens H, Streitbuerger A, Koehler G, Winkelmann W, Gosheger G, Hardes J (2009) Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol 135(1), 149–158. [CrossRef] [PubMed] [Google Scholar]
  78. Su YP, Chen WM, Chen TH (2004) Giant-cell tumors of bone: an analysis of 87 cases. Int Orthop 28(4), 239–243. [PubMed] [Google Scholar]
  79. Lin WH, Lan TY, Chen CY, Wu K, Yang RS (2011) Similar local control between phenol- and ethanol-treated giant cell tumors of bone. Clin Orthop Relat Res 469(11), 3200–3208. [CrossRef] [PubMed] [Google Scholar]
  80. Benevenia J, Patterson FR, Beebe KS, Abdelshahed MM, Uglialoro AD (2012) Comparison of phenol and argon beam coagulation as adjuvant therapies in the treatment of stage 2 and 3 benign-aggressive bone tumors. Orthopedics 35(3), e371–e378. [PubMed] [Google Scholar]
  81. Malawer MM, Bickels J, Meller I, Buch RG, Henshaw RM, Kollender Y (1999) Cryosurgery in the treatment of giant cell tumor. A long-term followup study. Clin Orthop Relat Res 359, 176–188. [CrossRef] [Google Scholar]
  82. Marcove RC, Sheth DS, Brien EW, Huvos AG, Healey JH (1994) Conservative surgery for giant cell tumors of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision. Cancer 74(4), 1253–1260. [CrossRef] [PubMed] [Google Scholar]
  83. Schreuder HW, Keijser LC, Veth RP (1999) Beneficial effects of cryosurgical treatment in benign and low-grade-malignant bone tumors in 120 patients. Ned Tijdschr Geneeskd 143(45), 2275–2281. [PubMed] [Google Scholar]
  84. Marcove RC, Weis LD, Vaghaiwalla MR, Pearson R (1978) Cryosurgery in the treatment of giant cell tumors of bone: a report of 52 consecutive cases. Clin Orthop Relat Res 134, 275–289. [Google Scholar]
  85. Jacobs PA, Clemency REJr. (1985) The closed cryosurgical treatment of giant cell tumor. Clin Orthop Relat Res 192, 149–158. [Google Scholar]
  86. Alkalay D, Kollender Y, Mozes M, Meller I (1996) Giant cell tumors with intraarticular fracture. Two-stage local excision, cryosurgery and cementation in 5 patients with distal femoral tumor followed for 2–4 years. Acta Orthop Scand 67(3), 291–294. [CrossRef] [PubMed] [Google Scholar]
  87. Abdelrahman M, Bassiony AA, Shalaby H, Assal MK (2009) Cryosurgery and impaction subchondral bone graft for the treatment of giant cell tumor around the knee. HSS J 5(2), 123–128. [CrossRef] [PubMed] [Google Scholar]
  88. Wittig JC, Simpson BM, Bickels J, Kellar-Graney KL, Malawer MM (2001) Giant cell tumor of the hand: superior results with curettage, cryosurgery, and cementation. J Hand Surg Am 26(3), 546–555. [CrossRef] [PubMed] [Google Scholar]
  89. Nishisho T, Hanaoka N, Endo K, Takahashi M, Yasui N (2011) Locally administered zoledronic acid therapy for giant cell tumor of bone. Orthopedics 34(7), e312–e315. [PubMed] [Google Scholar]
  90. Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, Liu W (2012) Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am 94(5), 461–467. [CrossRef] [PubMed] [Google Scholar]
  91. Moon MS, Kim SS, Moon JL, Kim SS, Moon H (2013) Treating giant cell tumours with curettage, electrocautery, burring, phenol irrigation, and cementation. J Orthop Surg (Hong Kong) 21(2), 209–212. [CrossRef] [PubMed] [Google Scholar]
  92. van der Heijden L, van der Geest IC, Schreuder HW, van de Sande MA, Dijkstra PD (2014) Liquid nitrogen or phenolization for giant cell tumor of bone? A comparative cohort study of various standard treatments at two tertiary referral centers. J Bone Joint Surg Am 96(5), e35. [CrossRef] [PubMed] [Google Scholar]
  93. Veth R, Schreuder B, van Beem H, Pruszczynski M, de Rooy J (2005) Cryosurgery in aggressive, benign, and low-grade malignant bone tumours. Lancet Oncol 6(1), 25–34. [CrossRef] [PubMed] [Google Scholar]
  94. Lopez-Pousa A, Martin Broto J, Garrido T, Vazquez J (2015) Giant cell tumour of bone: new treatments in development. Clin Transl Oncol 17(6), 419–430. [CrossRef] [PubMed] [Google Scholar]
  95. Group ESESNW (2014) Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3), 113–123. [Google Scholar]
  96. Cheng YY, Huang L, Lee KM, Xu JK, Zheng MH, Kumta SM (2004) Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif Tissue Int 75(1), 71–77. [CrossRef] [PubMed] [Google Scholar]
  97. Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF (2008) Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone 42(1), 68–73. [CrossRef] [PubMed] [Google Scholar]
  98. Balke M, Campanacci L, Gebert C, Picci P, Gibbons M, Taylor R, Hogendoorn P, Kroep J, Wass J, Athanasou N (2010) Bisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of bone. BMC Cancer 10, 462. [CrossRef] [PubMed] [Google Scholar]
  99. Yasko AW (2006) Interferon therapy for giant cell tumor of bone. Curr Opinion Orthop 17(6), 568–572. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.